Abstract:The Rb/E2F network has a critical role in regulating cell cycle progression and cell fate decisions. It is dysfunctional in virtually all human cancers, because of genetic lesions that cause overexpression of activators, inactivation of repressors, or both. Paradoxically, the downstream target of this network, E2F1, is rarely strongly overexpressed in cancer. E2F1 can induce both proliferation and apoptosis but the factors governing these critical cell fate decisions remain unclear. Previous studies have focused on qualitative mechanisms such as differential cofactors, posttranslational modification or state of other signaling pathways as modifiers of the cell fate decisions downstream of E2F1 activation. In contrast, the importance of the expression levels of E2F1 itself in dictating the downstream phenotypes has not been rigorously studied, partly due to the limited resolution of traditional population-level measurements. Here, through single-cell quantitative analysis, we demonstrate that E2F1 expression levels have a critical role in determining the fate of individual cells. Low levels of exogenous E2F1 promote proliferation, moderate levels induce G1, G2 and mitotic cell cycle arrest, and very high levels promote apoptosis. These multiple anti-proliferative mechanisms result in a strong selection pressure leading to rapid elimination of E2F1-overexpressing cells from the population. RNA-sequencing and RT-PCR revealed that low levels of E2F1 are sufficient to induce numerous cell cycle-promoting genes, intermediate levels induce growth arrest genes (i.e., p18, p19 and p27), whereas higher levels are necessary to induce key apoptotic E2F1 targets APAF1, PUMA, HRK and BIM. Finally, treatment of a lung cancer cell line with a proteasome inhibitor, MLN2238, resulted in an E2F1-dependent mitotic arrest and apoptosis, confirming the role of endogenous E2F1 levels in these phenotypes. The strong anti-proliferative activity of moderately overexpressed E2F1 in multiple cancer types suggests that targeting E2F1 for upregulation may represent an attractive therapeutic strategy in cancer.

miR-449a and miR-449b are direct transcriptional targets of E2F1 and negatively regulate pRb-E2F1 activity through a feedback loop by targeting CDK6 and CDC25A.

YY1 Promotes Colorectal Cancer Proliferation Through the Mir-526B-3p/e2f1 Axis.

[miR-449a/b negatively regulates E2F1 to suppress proliferation of gastric cancer cells]

miR-203 is a direct transcriptional target of E2F1 and causes G1 arrest in esophageal cancer cells.

E2F-1 Targets Mir-519D to Regulate the Expression of the Ras Homolog Gene Family Member C

Eef-2 Kinase-targeted Mir-449B Confers Radiation Sensitivity to Cancer Cells.

E2F1 and RNA binding protein QKI comprise a negative feedback in the cell cycle regulation.

1069 MicroRNA-143 is a Potential Tumor Suppressor Targeting DNA Methyltransferases 3a in Colorectal Cancer

Inhibition of Rb Phosphorylation Leads to Mtorc2-Mediated Activation of Akt

E2f4-Rb and E2f4-P107 Complexes Suppress Gene Expression by Transforming Growth Factor Beta Through E2f Binding Sites

Dynamical behaviors of Rb-E2F pathway including negative feedback loops involving miR449

Tumor-suppressive microRNA-449a induces growth arrest and senescence by targeting E2F3 in human lung cancer cells

MicroRNA-449a Inhibits Proliferation and Induces Apoptosis by Directly Repressing E2F3 in Gastric Cancer

SUMOylation of Rb Enhances Its Binding with CDK2 and Phosphorylation at Early G1 Phase

Expression level is a key determinant of E2F1-mediated cell fate

E2F transcription factor 1 is involved in the phenotypic modulation of esophageal squamous cell carcinoma cells via microRNA-375

Stabilization of E2F1 Protein by MDM2 Through the E2F1 Ubiquitination Pathway

c-Myc-regulated microRNAs modulate E2F1 expression

PRMT4-Mediated Arginine Methylation Negatively Regulates Retinoblastoma Tumor Suppressor Protein and Promotes E2F-1 Dissociation

MiR-532-5p Suppresses Renal Cancer Cell Proliferation by Disrupting the ETS1-mediated Positive Feedback Loop with the KRAS-NAP1L1/P-ERK Axis

The Retinoblastoma Protein Selectively Represses E2F1 Targets Via a TAAC DNA Element During Cellular Senescence*